Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-207

@Eggboy
I tend to agree with your assessment of LC’s comments. (Assuming you are thinking LC was trying to portray that the results are good).

It did appear to convey to the audience, whether by intention or just an ‘off the cuff’ comment, that the results are at a level not seen before in any of the trials LC has conducted and therefore one could be excused for believing that the results are quite good. If the results are not good, then LC will need to have communication skills training, because I am one of the investors who is believing the results are quite good!

Let’s see what happens in due course. TB is on point. We will all know soon if we are quite wealthy or holding a dud.

GLTAH. Some excellent posting by the way from a good many investors here just recently.